
Articles
-
2 days ago |
fabbaloo.com | Charles R. Goulding
Charles R. Goulding and Preeti Sulibhavi explore how Kind Designs is pioneering 3D printed Living Seawalls that defend coastlines while reviving marine ecosystems. In the face of escalating climate threats, Miami-based startup Kind Designs is redefining coastal resilience with its innovative 3D printed Living Seawalls. These structures not only shield shorelines from erosion and flooding but also foster marine biodiversity, setting a new standard in sustainable infrastructure.
-
3 days ago |
fabbaloo.com | Charles R. Goulding
Charles R. Goulding and Preeti Sulibhavi discover how Rice University’s bold transparency in research funding sets a powerful new standard for efficiency, sustainability, and 3D printing innovation. As federal research grants come under increased scrutiny in Washington, the higher education sector is being asked difficult questions: How are billions in taxpayer dollars spent? Are institutions doing enough to maximize impact and minimize waste?
-
6 days ago |
fabbaloo.com | Charles R. Goulding
Charles R. Goulding and Preeti Sulibhavi explore how Heineken’s embrace of 3D printing and R&D strategies is reshaping the brewing industry for a high-tech future. Heineken N.V., the world’s second-largest brewer, continues to lead the global beer industry with its commitment to innovation and efficiency.
-
1 week ago |
fabbaloo.com | Charles R. Goulding
Charles R. Goulding and Preeti Sulibhavi underscore how top consulting firms are pivoting toward 3D printing in response to shrinking federal contracts and rising demand in defense and industry. A quiet shift is taking place in the consulting world. The Department of Government Efficiency (DOGE) has drastically reduced billions of dollars in federal contract awards to the top ten consulting firms.
-
1 week ago |
fabbaloo.com | Charles R. Goulding
Charles R. Goulding and Preeti Sulibhavi examine how 3D printing and domestic production strategies are revolutionizing drug manufacturing and paving the way for a resilient, patient-centered pharmaceutical future. The COVID-19 pandemic exposed critical vulnerabilities in the global pharmaceutical supply chain, prompting a reevaluation of drug manufacturing strategies.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →